Although we initially revealed several potential biomarkers using machine learning in this study that have a high diagnostic value for asthma, further examination of CD300E and IER2 expression levels in hospital-constructed asthma cohorts is necessary to verify the diagnostic power of these marker genes before they can be clinically used. The gene discussed is CD300E; the disease is asthma.